Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025)
Protagonist Therapeutics (PTGX) posted Current Taxes of $1.9 million for Q1 2025, down 29.75% sequentially from $2.7 million in Q4 2024, and down 43.21% YoY from $3.3 million in Q1 2024.
Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025) Analysis & Trends
Protagonist Therapeutics has reported Current Taxes for 3 years, with the latest figure at $1.9 million in Q1 2025.
- Quarterly Current Taxes fell 43.21% year-over-year to $1.9 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.9 million (down 43.21% YoY) and the FY2024 annual result came in at $2.7 million, changed N/A from the prior year.
- Current Taxes slipped to $1.9 million in Q1 2025 per PTGX's latest filing, from $2.7 million in the prior quarter.
- Over five years, Current Taxes peaked at $3.3 million in Q1 2024 and troughed at $1.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Protagonist Therapeutics | 10.03 Bn | 10.03 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 3.33 Mn |
| Jun 30, 2018 | 276,000.00 |
| Mar 31, 2018 | 379,000.00 |